Patent · US Active

Multi-specific antibodies for cross-neutralization of multiple filovirus glycoproteins

US10391171B2 · kind B2 · utility

2Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2017
Grant dateAug 27, 2019
Priority date—
Expiry dateJan 12, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for treating and for preventing Filovirus infections are disclosed, as well as compositions therefor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.